M. Clanet

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

Chris H. Polman, Stephen C. Reingold, Brenda Banwell et al. · Annals of Neurology · 2011 · 9.8K citations · Full text

Medicine, Neurology, Neuroscience +10

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

Xavier Montalbán, Ralf Gold, Alan J. Thompson et al. · Multiple Sclerosis Journal · 2018 · 705 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +12

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial

Ludwig Kappos, Giancarlo Comi, Hillel Panitch et al. · Nature Medicine · 2000 · 514 citations

Life Sciences, Immunology, Neurology +17

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.

Gilles Edan, David Miller, M. Clanet et al. · Journal of Neurology Neurosurgery & Psychiatry · 1997 · 422 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +12

<scp>ECTRIMS</scp>/<scp>EAN</scp> guideline on the pharmacological treatment of people with multiple sclerosis

Xavier Montalbán, Ralf Gold, Alan J. Thompson et al. · European Journal of Neurology · 2018 · 222 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12